Operating Lease, Right-of-Use Asset of Cyclo Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cyclo Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2024.
  • Cyclo Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2024 was $26,636, a 41% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Cyclo Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $26,636 -$18,183 -41% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $245,552 +$196,405 +400% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $569,476 +$516,083 +967% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $890,949 +$889,479 +60509% 31 Dec 2023 10-K/A 18 Dec 2024 2024 FY
Q3 2023 $44,819 +$39,150 +691% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $49,147 +$39,069 +388% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $53,393 +$38,905 +269% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $1,470 -$16,166 -92% 31 Dec 2022 10-K/A 18 Dec 2024 2024 FY
Q3 2022 $5,669 -$16,375 -74% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $10,078 -$16,375 -62% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $14,488 -$16,374 -53% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $17,636 -$16,375 -48% 31 Dec 2021 10-K 17 Mar 2023 2022 FY
Q3 2021 $22,044 -$16,304 -43% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $26,453 -$16,062 -38% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $30,862 -$15,904 -34% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $34,011 -$17,006 -33% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q3 2020 $38,348 -$16,920 -31% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $42,515 -$17,004 -29% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $46,766 -$17,005 -27% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 $51,017 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 $55,268 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $59,519 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 $63,771 31 Mar 2019 10-Q 15 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.